Key facts
- This page summarizes Jennifer Yowler's Form 4 filing for BrightSpring Health Services, Inc. (BTSG).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Mar 2025, 18:20.
Jennifer Yowler - 17 Mar 2025 Form 4 Insider Report for BrightSpring Health Services, Inc. (BTSG)
- Reporting relationship
- President, PharMerica
- Issuer ticker
- BTSG
- Reported as of
- 17 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Mar 2025, 18:20:50 UTC
- Prior SEC filing
- 28 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Phipps, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jennifer Yowler filed Form 4 for BrightSpring Health Services, Inc. (BTSG) on 19 Mar 2025.
Change
- Previous filing in this sequence was filed on 28 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BTSG
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +23,029
- Change %
- +44%
- Price
- $0.000000
- Shares after
- 75,401
- Date
- 17 Mar 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BTSG
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +48,900
- Change %
- Price
- $0.000000
- Shares after
- 48,900
- Date
- 17 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 48,900
- Exercise price
- $17.45
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On March 17, 2025 the Reporting Person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2026. Each RSU represents a contingent right to receive one share of common stock upon settlement.
Footnote F2
Includes 38,589 shares of the Issuer's common stock underlying RSUs which will vest in two equal annual installments commencing on January 25, 2026 and 23,029 shares of the Issuer's common stock underlying RSUs which will vest in three equal annual installments commencing on January 25, 2026.
Footnote F3
Options vest in three equal annual installments commencing on January 25, 2026.